SHOT Urges Safe Component Matching While NHSBT Appeals for Black Donors
Serious Hazards of Transfusion (SHOT) shared a post on LinkedIn:
“As Sickle Cell Awareness Month begins, SHOT acknowledges the crucial role of transfusion support for many patients living with sickle cell disease.
SHOT reports continue to highlight the importance of selecting appropriately matched blood components, maintaining accurate and accessible transfusion histories, and ensuring effective communication between clinical and laboratory teams, particularly where patients receive care across multiple organisations.
Learning from haemovigilance reports supports improvements in transfusion safety and patient outcomes.”
NHS Blood and Transplant shared a post on LinkedIn:
“Today (September 1st) marks the start of Sickle Cell Awareness Month.
Sickle cell is a genetic hereditary blood disorder that makes it harder for the red cells to move around the body and they can stick together, blocking blood vessels which can cause excruciating pain, anaemia and organ damage.
It most commonly affects people from Black African or Black Caribbean backgrounds. Many patients with sickle cell rely on regular blood transfusions every 4 to 6 weeks.
To get the best treatment, people with sickle cell who have regular transfusions need blood that’s similar to their own. This is why we are using this month to appeal for more blood donors from Black African or Black Carribbean backgrounds.
Book your next appointment now and help us to save lives.”
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 07:55Anu Thomas: A Stepwise Laboratory Approach to Positive IAT and Pretransfusion Compatibility
-
Oct 18, 2026, 07:49Matthew Hazell: Molecular Matching and the Future of Transfusion Practice
-
Oct 18, 2026, 07:05Behnood Bikdeli: Vasculearn Network Highlights Expert Perspectives on PE Risk Stratification and Advanced Therapies
-
Oct 18, 2026, 06:27Gregory Makris: NEJM Study Supports Earlier Catheter-Directed Intervention in Intermediate-High–Risk PE
-
Oct 18, 2026, 06:26Danny Hsu: BLOOD 2026 Return to Aotearoa
-
Oct 18, 2026, 02:43Priya Sriskandarajah: Diagnosis and Management of PV and JAK2-Unmutated Erythrocytosis
-
Oct 18, 2026, 02:41C. Michael Gibson: A Meta-Analysis of DOACs and DAPT After Left Atrial Appendage Closure
-
Oct 18, 2026, 02:27What Hematologists Should Remember About the Person Behind the Platelet Count – ASH
-
Oct 18, 2026, 01:44Marta Velia Antonini: How to Deliver CRRT during ECMO?